SNSS : Summary for Sunesis Pharmaceuticals, Inc. - Yahoo Finance

U.S. Markets closed

Sunesis Pharmaceuticals, Inc. (SNSS)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
4.02+0.02 (+0.50%)
At close: 4:00PM EST
People also watch
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close4.00
Bid0.00 x
Ask0.00 x
Day's Range3.93 - 4.08
52 Week Range2.64 - 6.30
Avg. Volume51,059
Market Cap83.93M
PE Ratio (TTM)-1.38
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Zacks2 days ago

    Aduro (ADRO) Inks License Agreement with Stanford University

    Aduro Biotech, Inc. (ADRO) announced that it has inked an exclusive license agreement with Stanford University for state-of-the-art neo-antigen identification technology.

  • Synergy (SGYP) Trulance Wins FDA Approval for Constipation
    Zacks2 days ago

    Synergy (SGYP) Trulance Wins FDA Approval for Constipation

    Synergy Pharmaceuticals Inc. (SGYP) announced that the FDA has approved one of its lead pipeline candidates, Trulance (plecanatide), for the treatment of adults suffering from chronic idiopathic constipation (CIC).

  • How MEI Pharma Inc (MEIP) Stacks Up Against Its Peers
    Insider Monkeylast month

    How MEI Pharma Inc (MEIP) Stacks Up Against Its Peers

    It is already common knowledge that individual investors do not usually have the necessary resources and abilities to properly research an investment opportunity. As a result, most investors pick their illusory “winners” by making a superficial analysis and research that leads to poor performance on aggregate. The Standard and Poor’s 500 Index returned 7.6% over […]